Certain Shares of Xbrane Biopharma AB (publ) are subject to a Lock-Up Agreement Ending on 29-SEP-2021. These Shares will be under lockup for 91 days starting from 30-JUN-2021 to 29-SEP-2021. Details: Members of the company’s board of directors and management, have, subject to customary exceptions, agreed to not sell their shares in the company for a period of 180 days after the date of registration of the shares issued in connection with the Directed Share Issue with the Swedish Companies Registration Office. The existing shareholders STADA Arzneimittel AG and Serendipity Group AB have, subject to customary exceptions, agreed to not sell their shares in the Company for a period of 90 calendar days after the date of registration of the shares issued in connection with the Directed Share Issue with the Swedish Companies Registration Office.